Carla Cisneros Sanchez

Institutions of which they are part

Pediatric Neurology

Vall Hebron Institut de Recerca

Carla Cisneros Sanchez

Institutions of which they are part

Pediatric Neurology

Vall Hebron Institut de Recerca

Related news

Entrega del xec solidari de l'associació ImpulsaT

ImpulsaT association awards €20,000 for research into LAMA2-deficient muscular dystrophy

The donation will enable further characterisation of patients with this rare disease, the identification of new biomarkers and the exploration of innovative therapies.

The FDA approves a treatment co-created at Vall d’Hebron for a rare muscle disease

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

A new clinical algorithm increases the diagnosis rate of rare diseases

The ClinPrior algorithm achieved a positive diagnosis rate of 70% in two minority diseases of neurodegenerative origin, which represents double the number of cases that are diagnosed with current tools.